Market Tracker

06/24 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

81.90
Delayed Data
As of Jun 24
 -6.30 / -7.14%
Today’s Change
75.90
Today|||52-Week Range
143.45
-34.91%
Year-to-Date
3 Biotech Stocks to Buy in the Wake of the Brexit Vote
Jun 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close88.20
Today’s open82.92
Day’s range81.82 - 85.79
Volume2,298,494
Average volume (3 months)1,973,856
Market cap$21.1B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+198.65%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book22.35

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-2.60-5.63%
ZTSZoetis Inc-1.39-2.90%
INCYIncyte Corp-4.68-5.73%
ALXNAlexion Pharmaceutic...-10.58-8.56%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts